1996
DOI: 10.1038/bjc.1996.58
|View full text |Cite|
|
Sign up to set email alerts
|

The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
48
1

Year Published

1998
1998
2010
2010

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 67 publications
(56 citation statements)
references
References 62 publications
7
48
1
Order By: Relevance
“…However, for the Photofrin-dextrose delivery, the specific uptake ratio, given by tumor tissue concentration per normal brain tissue concentration, is comparable to the ratios in Muller and Lilge's work [6,14]. The specific uptake ratio for Photofrin-DPPC liposomes is significantly higher than that for Photofrin-dextrose delivery in our present study.…”
Section: Discussionsupporting
confidence: 87%
See 2 more Smart Citations
“…However, for the Photofrin-dextrose delivery, the specific uptake ratio, given by tumor tissue concentration per normal brain tissue concentration, is comparable to the ratios in Muller and Lilge's work [6,14]. The specific uptake ratio for Photofrin-DPPC liposomes is significantly higher than that for Photofrin-dextrose delivery in our present study.…”
Section: Discussionsupporting
confidence: 87%
“…The uptake, given by tissue concentration (tumor, BAT, normal brain) per injected Photofrin dose, is lower in this rat model compared with the clinical studies of Muller and Wilson [6], as well as the preclinical rabbit studies by Lilge et al [14]. However, for the Photofrin-dextrose delivery, the specific uptake ratio, given by tumor tissue concentration per normal brain tissue concentration, is comparable to the ratios in Muller and Lilge's work [6,14].…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…This treatment modality is referred to as interstitial photodynamic therapy (iPDT). Its feasibility and effectiveness has been investigated in brain tumor models [11,12] and in first clinical applications with Photofrin [13][14][15][16]. Unfortunately, prolonged skin sensitization and damage to normal brain tissue due to the limited selectivity of the applied PS (Photofrin or Photofrin II) have obstructed the broad application of this potentially minimal invasive treatment concept.…”
Section: Introductionmentioning
confidence: 99%
“…PDT is being investigated as a possible adjunctive approach to surgical resection [15,16]. High fluence rate PDT of the tumor resection cavity can lead to necrosis of the remaining tumor cells [17]. However, brain tissue is extremely sensitive to immune responses caused by tumor cell necrosis [14].…”
Section: Introductionmentioning
confidence: 99%